Clinical Trial Update: Oxytocin in Adolescents With Autism Spectrum Disorders [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for oxytocin in adolescents with autism spectrum disorder, involving Phase 2 and Phase 3 cohorts; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Autism Spectrum Disorder | Phase 2, Phase 3 | Status: TERMINATED